Matches in Wikidata for { <http://www.wikidata.org/entity/Q66080040> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q66080040 description "clinical trial" @default.
- Q66080040 description "ensayu clínicu" @default.
- Q66080040 description "klinisch onderzoek" @default.
- Q66080040 description "клінічне випробування" @default.
- Q66080040 description "կլինիկական փորձարկում" @default.
- Q66080040 name "Safety And Efficacy Study Of Orally Administered DS102 In Patients With NAFLD" @default.
- Q66080040 name "Safety And Efficacy Study Of Orally Administered DS102 In Patients With NAFLD" @default.
- Q66080040 type Item @default.
- Q66080040 label "Safety And Efficacy Study Of Orally Administered DS102 In Patients With NAFLD" @default.
- Q66080040 label "Safety And Efficacy Study Of Orally Administered DS102 In Patients With NAFLD" @default.
- Q66080040 prefLabel "Safety And Efficacy Study Of Orally Administered DS102 In Patients With NAFLD" @default.
- Q66080040 prefLabel "Safety And Efficacy Study Of Orally Administered DS102 In Patients With NAFLD" @default.
- Q66080040 P1050 Q66080040-D0A4322F-67E6-4BCB-A249-6EA5B201C67E @default.
- Q66080040 P1132 Q66080040-A375B0C8-89C2-46E1-98FC-055724482226 @default.
- Q66080040 P1476 Q66080040-D353E079-4F02-4F69-AA19-68382107D3F4 @default.
- Q66080040 P17 Q66080040-6F9A0FA4-6C4A-479C-ACAC-4D3B724DAD89 @default.
- Q66080040 P17 Q66080040-85EDCA00-4AC4-46A0-9907-E243BB5C1FA1 @default.
- Q66080040 P17 Q66080040-9C5CEBC0-984B-4736-BBC4-9A12E725F256 @default.
- Q66080040 P17 Q66080040-F93A6F1E-74A3-4EFE-ADB5-D6C1505C7355 @default.
- Q66080040 P2899 Q66080040-169C2339-D043-4A75-AB48-A24575F81AF3 @default.
- Q66080040 P3098 Q66080040-F3C7C376-DF08-4F99-AE75-9FD7E3D478D3 @default.
- Q66080040 P31 Q66080040-2FC3A021-D71C-4B74-B235-4A189013CBF4 @default.
- Q66080040 P4135 Q66080040-4D6E4AB6-7470-47F7-A521-2CE2E9F4D5F7 @default.
- Q66080040 P580 Q66080040-2CCB36E4-BCDF-4A40-B07A-2B8E6F64F117 @default.
- Q66080040 P582 Q66080040-E0A4E961-CA26-47A5-8AF6-517F1137CB15 @default.
- Q66080040 P6099 Q66080040-3372746B-BA15-455B-93F4-A07E07985A7E @default.
- Q66080040 P8363 Q66080040-D34572F9-8E4E-4A5D-BFC8-A7FE64053C3B @default.
- Q66080040 P1050 Q1546498 @default.
- Q66080040 P1132 "+69" @default.
- Q66080040 P1476 "A Randomised, Double-Blind, Placebo-Controlled, Exploratory Phase IIa Study To Assess The Safety And Efficacy Of Orally Administered DS102 In NAFLD Patients." @default.
- Q66080040 P17 Q145 @default.
- Q66080040 P17 Q212 @default.
- Q66080040 P17 Q230 @default.
- Q66080040 P17 Q29 @default.
- Q66080040 P2899 "+18" @default.
- Q66080040 P3098 "NCT02941549" @default.
- Q66080040 P31 Q30612 @default.
- Q66080040 P4135 "+75" @default.
- Q66080040 P580 "2016-11-24T00:00:00Z" @default.
- Q66080040 P582 "2018-12-01T00:00:00Z" @default.
- Q66080040 P6099 Q42824440 @default.
- Q66080040 P8363 Q78089383 @default.